SanBio Company Limited [4592.T]
TOKYO, Jun 15 (Pulse News Wire) – SanBio Company Limited (4592.T) reported foreign exchange gains and tax adjustments for its fiscal first quarter ending April 30, 2026. The company recorded a foreign exchange gain of ¥177 million due to fluctuations in foreign currency rates, primarily affecting loans and related receivables denominated in foreign currencies extended to its consolidated subsidiaries.
Additionally, the firm recognized deferred tax liabilities associated with these foreign currency-denominated loans and receivables, resulting in a tax adjustment of ¥55 million. The impact of these non-operating items on the company's performance will be detailed in the interim earnings release published today.
Separately, changes in the foreign currency translation adjustments amounting to -¥136 million have been included in other comprehensive income adjustments. For further specifics on how these figures affect overall financial results, interested stakeholders should consult the company’s “Interim Report for the First Quarter Ending April 30, 2026” released concurrently.
🟢 Confidence: High AI-translated content.